Oscar Health (OSCR)
(Delayed Data from NYSE)
$17.72 USD
+0.99 (5.92%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $17.73 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.72 USD
+0.99 (5.92%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $17.73 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Zacks News
Should You Invest in the SPDR S&P Insurance ETF (KIE)?
by Zacks Equity Research
Sector ETF report for KIE
AIZ vs. OSCR: Which Stock Is the Better Value Option?
by Zacks Equity Research
AIZ vs. OSCR: Which Stock Is the Better Value Option?
Oscar Health, Inc. (OSCR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Oscar Health (OSCR) delivered earnings and revenue surprises of 25% and 1.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's What to Expect From HCI Group (HCI) in Q2 Earnings
by Zacks Equity Research
HCI Group's (HCI) second-quarter results are likely to benefit from better performances across its business units.
Is a Beat in Store for Oscar Health (OSCR) in Q2 Earnings?
by Zacks Equity Research
Oscar Health's (OSCR) Q2 results are likely to reflect membership growth, prudent pricing and improved cost-of-care initiatives.
Here's What to Expect From Assurant (AIZ) in Q2 Earnings
by Zacks Equity Research
Assurant's (AIZ) Q2 results are likely to reflect higher yields and assets in fixed maturity securities, lower catastrophe reinsurance premiums, higher premium rates and growth in Connected Living.
ETFs & Stocks in Focus on Kamala Harris' Shift in Strategy
by Sanghamitra Saha
Analysts have noticed that Harris's 2024 campaign for president is a bit different than what it was in 2024, as quoted on yahoo finance.
Prudential (PRU) Misses Q2 Earnings Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -1.17% and 0.41%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Enact Holdings (ACT) delivered earnings and revenue surprises of 23.30% and 2.29%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $17.68, representing a +1.67% change from its previous close.
Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Oscar Health (OSCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Allstate (ALL) Q2 Earnings Beat Estimates on Premium Growth?
by Zacks Equity Research
Allstate's (ALL) second-quarter results are likely to reflect growing net investment income.
Will American International's (AIG) Q2 Earnings Hit a Pothole?
by Zacks Equity Research
American International's (AIG) second-quarter results are likely to reflect lower profits from General Insurance.
Will Prudential (PRU) Pull Off a Surprise in Q2 Earnings?
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to reflect higher spread income, equity market appreciation and growth in indexed variable annuities, partially offset by lower underwriting results.
Is Oscar Health (OSCR) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Oscar Health, Inc. (OSCR) and Acadia Realty Trust (AKR) have performed compared to their sector so far this year.
Will Rising Expenses Play Spoilsport for AON's Q2 Earnings?
by Zacks Equity Research
AON's second-quarter results are likely to reflect growing contributions from its Health Solutions unit.
Do Options Traders Know Something About Oscar Health (OSCR) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Oscar Health (OSCR) stock based on the movements in the options market lately.
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
Oscar Health, Inc. (OSCR) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $16.19, representing a +1.19% change from its previous close.
Oscar Health, Inc. (OSCR) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Oscar Health, Inc. (OSCR) closed the most recent trading day at $16.59, moving +1.22% from the previous trading session.
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Oscar Health, Inc. (OSCR) and Palomar (PLMR) have performed compared to their sector so far this year.
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYX
Wall Street Bulls Look Optimistic About Oscar Health (OSCR): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Oscar Health (OSCR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
5 Low-Leverage Stocks to Buy as Inflation Data Meets Expectation
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may add VITL, TCOM, ATO, STRA & OSCR to your portfolio.
3 Insurance Stocks to Buy as Interest Rates Remain High
by Abhinab Dasgupta
American Coastal (ACIC), Hamilton Insurance (HG) and Oscar Health (OSCR) are three insurance stocks that you can look into as interest rates stay higher for longer.